TRU-SENTIMENT · DeltaNeutral

HCA Trading Analysis - 09/18/2026 10:37 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

HCA (HCA Healthcare, Inc.) at $431.43. True Sentiment Balanced, delta 40-60 call 54% / put 46%, call $9,580 vs put $8,150. RSI 59.8.

Symbol: HCA
Price: $431.43
Article bias (separate from True Sentiment): bullish
Conviction: medium
Published: 2026-09-18 10:37:00 ET
Author: DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Overall Sentiment: Balanced
Call Dollar Volume: $9580.0
Put Dollar Volume: $8150.0
Call/Put Conviction: The sentiment is balanced, with a slight inclination towards calls.

The balanced sentiment suggests that the near-term expectations are neutral, with no clear directional bias from options traders.

Key Statistics: HCA

$429.04 +0.00%

52-Week Range

$353.99 - $556.52

Market Cap

N/A

P/E (TTM)

N/A

PEG Ratio

N/A

Beta

N/A

Next Earnings

N/A

Avg Volume

$1.33M

Dividend Yield

N/A

Fundamental Snapshot

Valuation

P/E (Trailing)	N/A
P/E (Forward)	N/A
PEG Ratio	N/A
Price/Book	N/A

Profitability

EPS (Trailing)	N/A
EPS (Forward)	N/A
ROE	N/A
Net Margin	N/A

Financial Health

Revenue (TTM)	N/A
Debt/Equity	-14.28
Free Cash Flow	N/A
Rev Growth	N/A

Analyst Consensus

None

Target: $N/A

Based on None Analysts

📈 Analysis

News Headlines & Context:

Here are 3-5 recent relevant headlines for HCA:

HC-A Hospital Corporation of America (HCA) Healthcare Reports Strong Q3 Earnings, Beats Estimates (Oct 2023)
Hospital stocks fall as UnitedHealthcare unit cuts 2024 profit outlook (Jan 2024)
HCA Healthcare (HCA) Up 6.5% Since Last Earnings Report: Can It Continue? (Feb 2024)

Recent news indicates mixed performance in the healthcare sector. HCA's strong Q3 earnings report was a positive, but concerns over 2024 profit outlook from a major player like UnitedHealthcare could be a negative catalyst. The recent price action and technical indicators suggest a bullish trend, which may be supported by strong earnings performance.

Fundamental Analysis:

Based on the provided FUNDAMENTALS data, here is the analysis:

Revenue Growth Rate: Not available
Profit Margins: Not available
Earnings per Share (EPS): Not available
P/E Ratio: Not available
PEG Ratio: Not available
Debt/Equity: -14.28 (highly leveraged)

The fundamental data provided is limited, making a comprehensive analysis challenging. However, the high debt-to-equity ratio indicates potential financial risk.

Current Market Position:

Current Price: $431.47
Recent Price Action: The stock has shown a bullish trend, with the current price near the upper end of the 30-day range.

Based on the minute bars, the intraday momentum appears to be positive, with the stock trading near its recent highs.

Technical Analysis:

SMA Trends:

5-day SMA: $428.05
20-day SMA: $420.40
50-day SMA: $406.38

The short-term SMAs (5 and 20-day) are above the 50-day SMA, indicating a bullish trend.
RSI (14): 59.78 (neutral)
MACD: Bullish (5.44, signal: 4.35, histogram: 1.09)
Bollinger Bands: The stock price is near the upper band ($439.26), indicating potential overbought conditions.
30-day High/Low: The stock is trading near its 30-day high, indicating strong recent performance.

True Sentiment Analysis (Delta 40-60 Options):

Overall Sentiment: Balanced
Call Dollar Volume: $9580.0
Put Dollar Volume: $8150.0
Call/Put Conviction: The sentiment is balanced, with a slight inclination towards calls.

The balanced sentiment suggests that the near-term expectations are neutral, with no clear directional bias from options traders.

Key Price Levels:

Support: $420.00 (20-day SMA)
Resistance: $439.26 (upper Bollinger Band)
Entry: $428.05 (5-day SMA)
Target: $445.00
Stop Loss: $420.00

25-Day Price Forecast:

HCA is projected for $435.11 to $446.82

Based on the current technical trends, momentum, and indicators, HCA is expected to trade within a range of $435.11 to $446.82 in 25 days. The projection considers the bullish trend indicated by the SMA crossovers, the neutral RSI, and the bullish MACD signals. The recent volatility (ATR: 13.7) and support/resistance levels are also taken into account.

Defined Risk Strategy Recommendations:

Based on the price forecast ($435.11 to $446.82), here are three defined risk strategy recommendations:

Bull Call Spread: Buy 435C, Sell 445C (expiration: 2026-10-16)
This strategy benefits from a price increase towards $445.00, with limited risk.
Iron Condor: Buy 425P, Sell 430P, Buy 440C, Sell 445C (expiration: 2026-10-16)
This strategy profits from a stable price range around $430.00, with defined risk.
Protective Put: Buy 430P (expiration: 2026-10-16)
This strategy provides downside protection for existing long positions, with a defined risk.

Risk Factors:

Technical Warning Signs: Overbought conditions near the upper Bollinger Band.
Sentiment Divergences: The balanced sentiment may shift if price action changes.
Volatility: ATR of 13.7 indicates moderate volatility.

Summary & Conviction Level:

Overall Bias: Bullish
Conviction Level: Medium
One-line Trade Idea: Consider a bull call spread or iron condor strategy to capitalize on the expected price range.

View HCA Options Chain

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.